Correlation between Hormonal Statuses and Metabolic Syndrome in Postmenopausal Women
,
Abstract
Objective: To compare the hormonal status in postmenopausal women with and without metabolic syndrome.
Materials and methods:In this cross sectional study 110 postmenopausal women were enrolled. Participants completed a questionnaire and underwent a medical exam and serum evaluation for serum lipids including cholesterol (Chol), high density lipoprotein cholesterol (HDL), low density lipoprotein (LDL), triglyceride (TG), fasting blood sugar (FBS), sex hormone binding globulin (SHBG), estradiol and testosterone. Metabolic syndrome was defined according to the definition of the National Cholesterol Education Program- Adult Treatment Panel III. In this study P value less than 0.05 was accepted as significant.
Results:There were significant differences between the two groups of participants with and without metabolic syndrome in age, years after menopause, BMI, weight, SHBG and testosterone (p< 0.01).
Conclusion: SHBG and testosterone are the most significant correlated factors to metabolic syndrome in postmenopausal women.
Cameron A. The metabolic syndrome: Validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction. Maturitas 2010; 65: 117-21.
Ding QF, Hayashi T, Zhang XJ, Funami J, Ge L, Li J, Huang XL,, et al. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopusal women. Journal of Diabetes and Its Complications 2007;21: 315-19.
Martínez MA, Puig JG, Mora M, Aragón R, O'Dogherty P, Antón JL,, et al. Metabolic syndrome: prevalence, associated factors, and C- reactive protein. The MADRIC ( MADrid RIesgo Cardiovascular) Study. Metabolism clinical and Exprimental 2008;57: 1232-40.
Gaspard U. Hyperinsulinaemia, a key factor of The metabolic syndrome in postmenopausal women. Maturitas 2009; 62:362-5.
Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults.Executive summary of the third report of the National Cholesterol Education Program(NCEP) Expert Panel on Detection ,Evaluation,and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel III).JAMA 2003;285:2486-97.
Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI; Postmenopausal Estrogen/Progestin Intervention Trial..Association of endogenous sex hormones and insulin resistance among postmenopausal women :Resultes from the Postmenopausal Estrogen/Intervention trial.J Clin Edocrinol Metab 2003;88:1646-52.
Oh JY, Barrett-Connor E, Wedick NM, Wingard DL; Rancho Bernardo Study..Endogenous sex hormones and the development of type 2 diabetes in older men and women:the Rancho Bernardo study.Diabetes Care 2002;25:55-60.
Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S,et al.Sex-hormone binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN).Circulation 2005;111:1242-9.
Korhonen S, Hippeläinen M, Vanhala M, Heinonen S, Niskanen L..The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women:a controlled community-based study.Fertil Steril 2003;79:1327-34.
Golden SH, Ding J, Szklo M, Schmidt MI, Duncan BB, Dobs A. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in ostmenopausal women: the atherosclerosis risk in communities study. .Am J Epidemiol 2004;160:540-8.
Hajamor S, Després JP, Couillard C, Lemieux S, Tremblay A, Prud'homme D,,et al.Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome.Metab 2003;52:724-30.
Rexrode KM, Manson JE, Lee IM, Ridker PM, Sluss PM, Cook NR,,et al.Sex hormone levels and risk of cardiovascular events in postmenopausal women.Circulation 2003;108:1688-93.
Tee de HJ, Lombard C, Deeks A A. Obesity, metabolic complications and the menopause: an opportunity for prevention. Climacteric 2010;13: 203-9.
Ebrahimpour P, Fakhrzadeh H, Heshmat R, Ghodsi M, Bandrian F, Larijani B. Metabolic syndrome and menopause: A population- based study. Diab Met Syndr: Clin Res Rev 2010;4:5-9.
Eshtiaghi R, Esteghamati A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas 2010;65:262-6.
Ainy E, Mirmiran P, Zahedi Asl S, Azizi F. Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS). Maturitas 2007; 58: 150-5.
Wu SI, Chou P, Tsai ST. The impact of years since menopause on the development of impaired glucose tolerance. J of Clin Epidemiol 2001; 54:117-20.
Weinberg ME, Manson JE, Buring JE, Cook NR, Seely EW, Ridker PM,et al.Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women.Metab Clin and Exper 2006;55:1473-80.
| Files | ||
| Issue | Vol 7, No 2 (June 2013) | |
| Section | Original Articles | |
| Keywords | ||
| hormonal status metabolic syndrome postmenopausal women | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
